title: Association of amyloid precursor protein-binding protein, family B, member 1 with nicotine dependence in African and European American smokers.
abstract: Although epidemiological studies reveal that cigarette smoking is inversely associated with Alzheimer's disease (AD) and Parkinson's disease (PD), the underlying mechanism remains largely unknown. Considering the facts that amyloid precursor protein-binding protein, family B, member 1 (APBB1) is mapped to a suggestive linkage region on chromosome 11 for nicotine dependence (ND), and has been implicated in the pathogenesis of AD and PD, it represents a plausible candidate for genetic study of ND. Five single nucleotide polymorphisms (SNPs) within APBB1 were genotyped in a sample consisting of 2,037 participants of either African-American (AA) or European-American (EA) origin, and examined their associations with ND assessed by three commonly used measures: Smoking Quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerström Test for ND (FTND). Individual SNP-based association analysis showed that all five SNPs are associated with at least one ND measure in one of the three samples; however, only the association of SNP rs4758416 with SQ and HSI remained significant after correction for multiple testing in the pooled sample. Haplotype analysis demonstrated three major haplotypes significantly associated with ND after Bonferroni correction. Formed by rs4758416-rs10839562-rs1079199, haplotype C-C-T showed positive association with FTND in the AA and pooled samples, and conversely, haplotype G-C-T showed negative association with SQ and HSI in AA and EA samples. Another haplotype, C-T-G, formed by rs10839562-rs1079199-rs8164, was significantly associated with HSI in the EA sample. Based on these findings, we conclude that APBB1 represents an important candidate gene in the genetic study on ND and neurodegenerative diseases and warrants further investigation in future.
authors.affiliation: Institute of Bioinformatics, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
authors.forename: Guo-Bo
authors.initials: GB
authors.lastname: Chen
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Payne
authors.forename: Xiang-Yang
authors.initials: XY
authors.lastname: Lou
authors.forename: Jennie Z
authors.initials: JZ
authors.lastname: Ma
authors.forename: Jun
authors.initials: J
authors.lastname: Zhu
authors.forename: Ming D
authors.initials: MD
authors.lastname: Li
mesh_terms: D000328:Adult; D001741:Black or African American / Q000235:genetics*; D005260:Female; D008040:Genetic Linkage; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D014029:Tobacco Use Disorder / Q000208:ethnology* / Q000235:genetics*; D014481:United States; D044465:White People / Q000235:genetics*
chemical_list: C091042:APBB1 protein, human; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins
references.citation: Addiction. 2003 Jan;98(1):23-31
references.pmid: 12492752
references.citation: Brain Res. 2006 Jun 6;1093(1):12-9
references.pmid: 16707114
references.citation: Nicotine Tob Res. 1999;1 Suppl 2:S51-7; discussion S69-70
references.pmid: 11768187
references.citation: Am J Hum Genet. 2006 Oct;79(4):745-51
references.pmid: 16960812
references.citation: Nicotine Tob Res. 2001 Aug;3(3):203-23
references.pmid: 11506765
references.citation: BMC Genet. 2003 Dec 31;4 Suppl 1:S103
references.pmid: 14975171
references.citation: J Psychopharmacol. 2004 Dec;18(4):457-74
references.pmid: 15582913
references.citation: Neurosci Lett. 2000 Dec 15;296(1):17-20
references.pmid: 11099823
references.citation: EMBO J. 2002 Nov 1;21(21):5691-700
references.pmid: 12411487
references.citation: Pharmacogenomics J. 2005;5(3):166-72
references.pmid: 15724146
references.citation: Nature. 1996 Jul 18;382(6588):255-7
references.pmid: 8717040
references.citation: Biostatistics. 2003 Apr;4(2):195-206
references.pmid: 12925516
references.citation: J Neurosci Res. 2004 Jan 1;75(1):12-24
references.pmid: 14689444
references.citation: Nat Cell Biol. 2008 Mar;10(3):283-94
references.pmid: 18278038
references.citation: Hum Genet. 2008 Mar;123(2):119-31
references.pmid: 18205015
references.citation: Hum Mol Genet. 2002 Feb 15;11(4):465-75
references.pmid: 11854179
references.citation: Science. 2002 Jun 21;296(5576):2225-9
references.pmid: 12029063
references.citation: J Neurosci. 2004 Apr 28;24(17):4259-65
references.pmid: 15115822
references.citation: Genet Epidemiol. 2004 Jan;26(1):61-9
references.pmid: 14691957
references.citation: Behav Brain Res. 2000 Aug;113(1-2):117-20
references.pmid: 10942038
references.citation: Hum Mol Genet. 2005 May 1;14(9):1211-9
references.pmid: 15790597
references.citation: Am J Hum Genet. 2004 Apr;74(4):765-9
references.pmid: 14997420
references.citation: Eur J Hum Genet. 2001 Jun;9(6):437-44
references.pmid: 11436125
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: J Biol Chem. 2007 Nov 16;282(46):33313-33325
references.pmid: 17855370
references.citation: JAMA. 2004 Mar 10;291(10):1238-45
references.pmid: 15010446
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):94-101
references.pmid: 15211640
references.citation: Am J Hum Genet. 1998 Jul;63(1):259-66
references.pmid: 9634505
references.citation: Clin Chest Med. 2000 Mar;21(1):189-97, x-xi
references.pmid: 10763099
references.citation: Lancet. 1992 May 23;339(8804):1268-78
references.pmid: 1349675
references.citation: Neurosci Lett. 2003 May 15;342(1-2):5-8
references.pmid: 12727304
references.citation: J Biol Chem. 1999 Mar 19;274(12):7952-7
references.pmid: 10075692
references.citation: Neurosci Lett. 2000 Oct 20;293(1):29-32
references.pmid: 11065130
references.citation: Inflamm Bowel Dis. 2004 Nov;10(6):848-59
references.pmid: 15626903